TOL.ST
Toleranzia AB [TOL.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
TOL.ST Stock Summary
Top 10 Correlated Stocks
TOL.ST
In the News
TOL.ST Financial details
Company Rating
Neutral
Market Cap
107.23M
Income
-7.46M
Revenue
39.8M
Book val./share
0.78
Cash/share
0.09
Dividend
-
Dividend %
-
Employees
12
Optionable
No
Shortable
Yes
Earnings
02 Nov 2020
P/E
-7.08
Forward P/E
-
PEG
3.18
P/S
-
P/B
0.35
P/C
5.64
P/FCF
-1.64
Quick Ratio
4.28
Current Ratio
4.53
Debt / Equity
0.01
LT Debt / Equity
-
-
-
EPS (TTM)
-0.06
EPS next Y
-
EPS next Q
-
EPS this Y
-26.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-35.71%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
1.04%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-5%
ROE
-6%
ROC
0.06%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.345-1.025
52W High
-
52W Low
-
RSI
54
Rel Volume
1.33
Avg Volume
138.21K
Volume
183.75K
Perf Week
2.63%
Perf Month
18.41%
Perf Quarter
37.3%
Perf Half Y
4.96%
-
-
-
-
Beta
1.313
-
-
Volatility
0.02%, 0.04%
Prev Close
-2.31%
Price
0.508
Change
-3.05%
TOL.ST Financial Performance
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.12 | 0.09 | 0.18 | 0.09 | 0 | |
| Net income per share | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | |
| Operating cash flow per share | 0 | -0.02 | -0.01 | 0 | -0.02 | |
| Free cash flow per share | -0.12 | -0.11 | -0.19 | -0.08 | -0.07 | |
| Cash per share | 0.31 | 0.2 | 0.01 | 0.28 | 0.09 | |
| Book value per share | 1.08 | 1.07 | 1.04 | 1.36 | 0.78 | |
| Tangible book value per share | 0.27 | 0.16 | -0.04 | 0.23 | 0.78 | |
| Share holders equity per share | 1.08 | 1.07 | 1.04 | 1.36 | 0.78 | |
| Interest debt per share | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Market cap | 123.55M | 105.68M | 93.55M | 60.47M | 84.35M | |
| Enterprise value | 90.47M | 84.93M | 93.69M | 28.81M | 66.89M | |
| P/E ratio | -15.1 | -13.57 | -9.34 | -13.75 | -11.05 | |
| Price to sales ratio | 9.3 | 10.43 | 4.76 | 6.04 | 0 | |
| POCF ratio | -241.79 | -47.93 | -75.56 | 451.24 | -27.98 | |
| PFCF ratio | -9.05 | -8.57 | -4.48 | -6.26 | -5.94 | |
| P/B Ratio | 1.03 | 0.9 | 0.81 | 0.39 | 0.55 | |
| PTB ratio | 1.03 | 0.9 | 0.81 | 0.39 | 0.55 | |
| EV to sales | 6.81 | 8.38 | 4.77 | 2.88 | 0 | |
| Enterprise value over EBITDA | -44.46 | -43.87 | -37.73 | -28.02 | -30.43 | |
| EV to operating cash flow | -177.04 | -38.52 | -75.68 | 214.96 | -22.19 | |
| EV to free cash flow | -6.63 | -6.88 | -4.48 | -2.98 | -4.71 | |
| Earnings yield | -0.02 | -0.02 | -0.03 | -0.02 | -0.02 | |
| Free cash flow yield | -0.11 | -0.12 | -0.22 | -0.16 | -0.17 | |
| Debt to equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Net debt to EBITDA | 16.26 | 10.72 | -0.06 | 30.8 | 7.94 | |
| Current ratio | 6.75 | 4.91 | 0.36 | 4.53 | 3.24 | |
| Interest coverage | 2.52K | -397.8 | -177.79 | -19.88 | -220.4 | |
| Income quality | 0.25 | 1.13 | 0.49 | -0.12 | 1.58 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.72 | 0.81 | 0.98 | 0.79 | 0 | |
| Capex to operating cash flow | 25.7 | 4.6 | 15.88 | -73.07 | 3.71 | |
| Capex to revenue | -0.99 | -1 | -1 | -0.98 | 0 | |
| Capex to depreciation | -2.63K | -1.69K | -3.28K | -1.63K | -1.87K | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0.67 | 0.65 | 0.73 | 0.54 | 0.41 | |
| ROIC | -0.93 | -0.02 | -0.02 | -0.01 | -0.01 | |
| Return on tangible assets | -0.06 | -0.08 | -1.12 | -0.03 | -0.01 | |
| Graham Net | 0.26 | 0.15 | -0.05 | 0.22 | 0.06 | |
| Working capital | 30.33M | 18.26M | -3.9M | 26.81M | 13.59M | |
| Tangible asset value | 29.58M | 17.5M | -4.67M | 26.03M | 153.52M | |
| Net current asset value | 29.48M | 17.41M | -4.75M | 25.96M | 12.74M | |
| Invested capital | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Average receivables | 1.58M | 1.5M | 1.39M | 1.67M | 1.62M | |
| Average payables | 2.94M | 3.58M | 3.77M | 5.02M | 5.14M | |
| Average inventory | -1.55M | -1.47M | -1.39M | -1.67M | -948K | |
| Days sales outstanding | 11.31 | 11.84 | 6.65 | 17.06 | 0 | |
| Days payables outstanding | -26.92 | -28.4 | -19.84 | -52.49 | 68.45K | |
| Days of inventory on hand | 10.87 | 11.84 | 6.65 | 17.43 | 0 | |
| Receivables turnover | 7.96 | 7.6 | 13.54 | 5.28 | 0 | |
| Payables turnover | -3.34 | -3.17 | -4.54 | -1.71 | 0 | |
| Inventory turnover | 8.28 | 7.6 | 13.54 | 5.16 | 0 | |
| ROE | -0.02 | -0.02 | -0.02 | -0.01 | -0.01 | |
| Capex per share | -0.12 | -0.09 | -0.18 | -0.09 | -0.06 |
TOL.ST Frequently Asked Questions
What is Toleranzia AB stock symbol ?
Toleranzia AB is a SE stock and trading under the symbol TOL.ST
What is Toleranzia AB stock quote today ?
Toleranzia AB stock price is $0.508 today.
Is Toleranzia AB stock public?
Yes, Toleranzia AB is a publicly traded company.
Company Profile
- Volume Average 138.21K
- Market Capitalization 107.23M
- Employee 12
- CEO Ms. Charlotte Fribert
- Headquarters Gothenburg,SE
- IPO Date 2015-12-16
-
Website
https://www.toleranzia.com 
Toleranzia AB, a biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases. The company is primarily developing TOL2 drug candidate for treating myasthenia gravis, an autoimmune nerve and muscle disease. It also intends to develop TOL3 drug candidate to treat ANCA vasculitis, an autoimmune blood vessel disease. In addition, the company develops tolerogens technology, a treatment method that creates disease-specific tolerance in the immune system for treating various autoimmune diseases. The company was founded in 2011 and is headquartered in Gothenburg, Sweden.
